Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sally Wenzel (Pittsburgh, United States of America). The omics approach to defining endotypes and personalising treatment pathways in asthma. International Congress 2016 – Endotyping: the means to personalised medicine in lung disease

Member's Comments

No comment yet.

Related content which might interest you: U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Application of 'omics to uncover novel disease pathways Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare Year: 2013 Asthma endotypes: a new approach to classification of disease entities within asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 The genetics of asthma and the promise of genomics-guided drug discovery Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Unbiased approaches to asthma stratification - the road to novel therapies Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018 Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013 Unbiased approaches to asthma stratification: the road to novel therapies Source: International Congress 2017 – PG15 Asthma stratification Year: 2017 Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Integration at the network- and pathway level of multi-omics data from multiple anatomical locations facilitate COPD sub-phenotyping in small cohorts Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018 Year: 2018 The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017 Unifying candidate gene and GWAS approaches in asthma Source: Annual Congress 2010 - Genetics of asthma Year: 2010 A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022